State Ledger
Company profile

Gain Therapeutics, Inc. CIK 1819411

Ticker
GANX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Bethesda, MD 20814
Fiscal year end
2025 (FY)
Market Data
Close
$1.57
Change
-$0.07
Change %
-4.27%
Volume
12,999

GANX · trading date Oct 12, 2026 · previous close $1.64 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$20.16M
Total assets
$22.82M
Total liabilities
$4.25M
Stockholders' equity
$18.56M
Cash & equivalents
$20.84M
Operating income
-$18.71M
Operating cash flow
-$18.47M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-26. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
18.6%
Equity / assets
81.4%
CapEx / revenue
—
Operating cash flow / net income
0.92×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$20.16M $22.82M $4.25M $18.56M
2024 — -$20.41M $12.12M $4.78M $7.34M
2023 $55.2K -$22.27M $18.61M $6.03M $12.58M
2022 $140.1K -$17.59M $24.10M $5.22M $18.88M
2021 $165.0K -$13.89M $38.99M $4.17M $34.82M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-11
Financials filed via
Form 10-K
filed 2026-03-26

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Bethesda, MD 20814
4800 HAMPDEN LANE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:33 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Maryland — Public Companies